ADMA Biologics director Guiheen sells 10,000 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ADMA Biologics director Lawrence P. Guiheen exercised options covering 10,000 shares at $5 per share on November 16, 2026, and sold 10,000 shares of common stock at $13.92 per share that day. As of the transaction date, his reported holdings included 58,254 shares and 5,345 unvested restricted stock units.
The option was exercised partly because of its near-term expiration. No Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F5, F6 | 10,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 10,000 | $5.00 | $50K |
| Sale | Common Stock F1, F2 | 10,000 | $13.92 | $139K |
| Holding | Common Stock F3 | -- | -- | -- |
| Holding | Common Stock F4 | -- | -- | -- |
Footnotes (6)
- F1. The price reported in Column 4 is the price at which the shares were sold.
- F2. Includes, as of the transaction date, (i) 5,345 unvested restricted stock units ("RSUs") granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date and that will be settled into common stock upon vesting; and (ii) 58,254 shares of common stock owned by the Reporting Person. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- F3. These shares are held in the Lawrence P Guiheen Revocable Trust DTD 9/20/19, over which the Reporting Person retains control.
- F4. These shares are held in the Lawrence P Guiheen Irrevocable Trust DTD 9/20/19, Arlene Guiheen TTEE, Katherine M Guiheen TTEE ("Guiheen Irrevocable Trust"), over which the Reporting Person retains control. The Reporting Person disclaims beneficial ownership of the securities held by the Guiheen Irrevocable Trust, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
- F5. The option was granted on February 14, 2017 and vested in twenty-four equal monthly installments, becoming fully vested on February 14, 2019.
- F6. The option terminates on the earlier of (i) February 14, 2027 and (ii) the one-year anniversary of the Reporting Person's ceasing to serve as a director of the Issuer. The Reporting Person is exercising this option due, in part, to its near-term expiration date.
Key Figures
Key Terms
restricted stock units financial
contingent right financial
vested financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why did ADMA director Lawrence P. Guiheen exercise his options?
AI-generated analysis. How Rhea-AI works. Not financial advice.